| Literature DB >> 30881614 |
Pravin C Patil1, Jinlian Tan2, Donald R Demuth2, Frederick A Luzzio1.
Abstract
Several 'second-generation' click inhibitors of the multi-species biofilm propagated by the adherence of the oral pathogen Porphyromonas gingivalis to Streptococcus gordonii were synthesized and evaluated. The design of the structures was based on the results obtained with the first-generation diphenyloxazole 'click' inhibitors which bear suitable hydrophobic and polar groups within a dual scaffold molecule bearing a 1,2,3-triazole spacer. The structures of the synthetic targets reported herein now consist of a triazolyl(phenylsulfonylmethyl) and a triazolyl(phenylsulfinylmethyl) spacer which joins a 4,5-diphenyloxazole with both phenyl rings bearing lipophilic substituents. The triazolyl "linker" group is formed by a click reaction between the 4-azido(phenylsulfonyl/sulfinylmethyl) oxazoles and acetylenic components having aryl groups bearing hydrophobic substituents. The 1,3,5-trisubstituted-2,4,6-triazine scaffold of the most active click compounds were modeled after the structural motif termed the VXXLL nuclear receptor (NR) box. When substituted at the 3- and 5-positions with 2- and 4-fluorophenylamino and N,N-diethylamino units, the candidates bearing the 1,3,5-trisubstituted-2,4,6-triazine scaffold formed a substantial subset of the second-generation click candidates. Four of the click products, compounds 95, 111, 115 and 122 showed inhibition of the adherence of P. gingivalis to S. gordonii with an IC50 range of 2.3-4.3 μM and only 111 exhibited cytotoxic activity against telomerase immortalized gingival keratinocytes at 60 μM. These results suggest that compounds 95, 115, 122, and possibly 111 represent the most suitable compounds to evaluate for activity in vivo.Entities:
Year: 2019 PMID: 30881614 PMCID: PMC6390472 DOI: 10.1039/c8md00405f
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597
Fig. 1General azide/alkyne scaffold construction of second-generation inhibitors via a ‘click’ reaction. The entire linker modality is a sulfinyl- or sulfonylphenyltriazole. NITVK locus = green; VXXLL locus = blue; yellow R = sulfinyl/sulfonyl.
Arylalkynyl click partners 16–27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arranged in order of increasing molecular weight.
Scheme 1Synthesis of azidophenylsulfinyl and azidophenylsulfonyl click partners 10–15. Reagents/conditions: (a) NaH/4-aminothiophenol/THF/0–5 °C to rt/16 h (66–85%). (b) NaNO2/10% HCl/NaN3/0–5 °C to rt/16 h (61–98%). (c) MCPBA (1.2 equiv.)/DCM/rt/16 h (86–95%). (d) MCPBA (3 eq.)/DCM/rt/16 h (86–93%).
Scheme 2Click reactions of azidophenylsulfoxides 10 and azidophenyl-sulfones 13 with selected arylacetylenes 16–24 to give Group I triazoles 28–45. aReagents/conditions: CuSO4·5H2O/Na ascorbate/THF–H2O (2 : 1).
Group I click products of azidophenylsulfoxides 10 and azidophenyl sulfones 13 with selected arylacetylenes 16–24
|
| |
| Compound | Yield |
|
| 46 |
|
| 86 |
|
| 97 |
|
| 95 |
|
| 60 |
|
| 58 |
|
| 39 |
|
| 79 |
|
| 89 |
|
| 73 |
|
| 63 |
|
| 69 |
|
| 98 |
|
| 54 |
|
| 97 |
|
| 77 |
|
| 97 |
|
| 63 |
Yields are for isolated pure compounds.
Scheme 3Click reactions of halogenated azidomethylsulfoxides 11 and 12 and azidophenylsulfones 14 and 15 with selected arylacetylenes 17–19 to give Group II click products 46–57. aReagents/conditions: CuSO4·5H2O/Na ascorbate/THF–H2O (2 : 1).
Group II click products 46–57 of halogenated azidomethylsulfoxides 11, 12 and azidophenyl sulfones 14, 15 with selected arylacetylenes 17–19
|
| |
| Compound | Yield |
|
| 78 |
|
| 83 |
|
| 92 |
|
| 52 |
|
| 93 |
|
| 76 |
|
| 79 |
|
| 83 |
|
| 95 |
|
| 84 |
|
| 93 |
|
| 81 |
Yields are for isolated pure compounds.
Scheme 4Synthesis of 2-(2-azidophenyl)-, 2-(3-azidophenyl)- and 2-(4-azidophenyl)-4,5-diaryloxazole click partners 73–87 through benzoin esters 58–72. Reagents/conditions: (a) DMAP/DCM/16 h. (b) NH4OAc/HOAc/115–120 °C/3–4 h. Yields are in parentheses.
Group III click products of azides 73–87 and acetylenes 25–27
|
| |
| Compound | Yield |
|
| 76 |
|
| 90 |
|
| 48 |
|
| 45 |
|
| 52 |
|
| 57 |
|
| 53 |
|
| 63 |
|
| 52 |
|
| 46 |
|
| 80 |
|
| 65 |
|
| 95 |
|
| 77 |
|
| 70 |
|
| 69 |
|
| 66 |
|
| 75 |
|
| 69 |
|
| 83 |
|
| 30 |
|
| 82 |
|
| 48 |
|
| 77 |
|
| 87 |
|
| 26 |
|
| 83 |
|
| 55 |
|
| 51 |
|
| 43 |
|
| 77 |
|
| 67 |
|
| 49 |
|
| 69 |
|
| 68 |
Yields are for isolated purified compounds.
Scheme 5Synthesis of the acetylenic triazine click partners 25–27. Reagents/conditions: (a) ethynyltrimethylsilane/n-BuLi/THF/0 °C/1 h; (b) 4-fluoroaniline, 2-fluoroaniline or diethylamine/THF/0 °C to rt/16 h; (c) TBAF/THF/0 °C to rt/2 h.
Scheme 6Click reactions of azides 73–87 with acetylenes 25–27 to give Group III triazole products 90–124. aConditions/reagents: CuSO4·5H2O/Na ascorbate/THF–H2O (2 : 1).
Fig. 2Inhibition of P. gingivalis (green) adherence to S. gordonii (red) by compound 111. Biofilms were formed in the presence of PBS/0.1% DMSO (A), or 5 μM (B), 20 μM (C), or 40 μM (D) compound 111.
IC50 values for Group I compounds (28–45), Group II compounds (46–57) and Group III compounds (90–124)
|
| IC50 |
| IC50 |
| IC50 |
|
| NA |
| 5.30 |
| 20.7 |
|
| NA |
| 35.9 |
| NA |
|
| 47.3 |
| 7.20 |
| NA |
|
| NA |
| 15.1 |
| 9.4 |
|
| NA |
| 39.8 |
| 16.0 |
|
| NA |
| 10.2 |
| 3.7 |
|
| NA |
| 40.0 |
| NA |
|
| NA |
| 40.0 |
| 36.6 |
|
| NA |
| 21.2 |
| NA |
|
| NA |
| 18.2 |
| NA |
|
| 15.7 |
| 6.3 |
| 9.6 |
|
| 33.6 |
| 20.0 |
| NA |
|
| 13.1 |
| 5.00 | ||
|
| NA |
| 12.3 | ||
|
| NA |
| 33.8 | ||
|
| 36.6 |
| NA | ||
|
| 16.5 |
| NA | ||
|
| 38.5 |
| 40.0 | ||
|
| NA | ||||
|
| NA | ||||
|
| NA | ||||
|
| 4.3 | ||||
|
| NA | ||||
|
| 49.2 | ||||
|
| NA | ||||
|
| 2.3 | ||||
|
| >40.0 | ||||
|
| 27.8 | ||||
|
| 13.3 | ||||
|
| NA | ||||
|
| NA | ||||
|
| NA | ||||
|
| 2.4 | ||||
|
| 8.00 | ||||
|
| 7.8 |
NA = not active.
Inhibition of planktonic growth
| Compound | IC50 (μM) | Percent inhibition of: | |
|
|
| ||
|
| 95.7 ± 1.2 | 94.2 ± 1.7 | |
|
| 3.7 | 0.4 ± 6.1 | –0.8 ± 2.8 |
|
| 4.3 | 8.3 ± 3.6 | 2.9 ± 3.9 |
|
| 2.3 | –2.8 ± 6.4 | –0.6 ± 5.8 |
|
| 2.4 | 2.5 ± 5.4 | –0.6 ± 3.9 |
|
| 21.2 | –3.4 ± 10.4 | –3.3 ± 6.0 |
|
| 6.3 | –2.7 ± 6.6 | 6.2 ± 8.8 |
|
| 9.4 | 2.0 ± 6.1 | –2.0 ± 8.9 |
|
| 5.0 | –8.3 ± 5.2 | –0.6 ± 0.8 |
|
| 12.3 | –1.3 ± 14.2 | –8.6 ± 2.0 |
Inhibition of planktonic growth by 10 μg ml–1 tetracycline.
Fig. 3Release of lactate dehydrogenase (LDH) activity (A) and measurement of ATP levels (B) in TIGK cells after 18 h exposure to peptidomimetic compounds. Concentrations of compounds used are as follows: 95 (5, 20 and 40 μM), 111 (5, 20, 60 μM), 115 (5, 10, 20 μM) and 122 (5, 20, 60 μM). The asterisk indicates a significant decrease in ATP relative to cells exposed to medium containing 0.1% DMSO; *p < 0.05.